Search
Google AI Drug Discovery Poised for Historic First Human Trials
3 day ago /
Read about 0 minute
Author：小编
Isomorphic Labs, a spin-off from Google DeepMind, is set to embark on a groundbreaking journey by initiating the first human trials of AI-designed anti-cancer drugs. In collaboration with leading pharmaceutical companies like Novartis and Eli Lilly, the firm aims to leverage AI technology to significantly boost the success rate of drug development and expedite the screening process for promising candidates. The integration of AI in the pharmaceutical sector is gaining momentum, with multinational pharmaceutical giants increasingly forging ties with AI-driven drug discovery firms through equity investments, pipeline licensing, joint R&D initiatives, and other innovative models.
-
C114 Communication Network -
Communication Home
7 X 24 Track global technological trends
